[EN] NEW DISUBSTITUTED PHENYLPIPERIDINES/PIPERAZINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION [FR] NOUVELLES PHENYLPIPERIDINES/PIPERAZINES DISUBSTITUES UTILISEES COMME MODULATEURS DE NEUROTRANSMISSION DE LA DOPAMINE
DISUBSTITUTED PHENYLPIPERIDINES/PIPERAZINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION
申请人:Sonesson Clas
公开号:US20070149542A1
公开(公告)日:2007-06-28
The present invention relates to compounds which have therapeutic effects against disorders in the central nervous system, and in particular new 4-(ortho,meta-disubstituted phenyl)-1-alkypiperidines and piperazines.
wherein R1, R2, R3 and X are as defined.
NEW DISUBSTITUTED PHENYLPIPERIDINES AS MODULATORS OF DOPAMINE AND SEROTONIN NEUROTRANSMISSION
申请人:Sonesson Clas
公开号:US20070179185A1
公开(公告)日:2007-08-02
The present invention relates to compounds which have therapeutic effects against disorders in the central nervous system, and in particular new 4-(ortho,meta-disubstituted phenyl)-1-alkypiperidines.
wherein R1, R2, and R3 are as defined.
Disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
申请人:NSAB, Filial AF Neurosearch Sweden AB, Sverige
公开号:US07763639B2
公开(公告)日:2010-07-27
The present invention relates to compounds which have therapeutic effects against disorders in the central nervous system, and in particular new 4-(ortho, meta-disubstituted phenyl)-1-alkypiperidines and piperazines.
wherein R1, R2, R3 and X are as defined.
DISUBSTITUTED PHENYLPIPERDINES/PIPERAZINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION
申请人:Sonesson Clas
公开号:US20100256163A1
公开(公告)日:2010-10-07
The present invention relates to compounds which have therapeutic effects against disorders in the central nervous system, and in particular new 4-(ortho,meta-disubstituted phenyl)-1-alkypiperidines and piperazines.
wherein R1, R2, R3 and X are as defined.
Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission
申请人:NSAB, Filial af Neurosearch Sweden AB, Sverige
公开号:US08314126B2
公开(公告)日:2012-11-20
The present invention relates to compounds which have therapeutic effects against disorders in the central nervous system, and in particular new 4-(ortho,meta-disubstituted phenyl)-1-alkypiperidines and piperazines.
wherein R1, R2, R3 and X are as defined.